Cortactin in cell migration and cancer at a glance

Journal of Cell Science

Volumn 125, Issue 7, 2012, Pages 1621-1626

  MacGrath, Stacey M ^a   Koleske, Anthony J ^a,b  

^a YALE UNIVERSITY   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CORTACTIN; NEURAL WISKOTT ALDRICH SYNDROME PROTEIN; SCATTER FACTOR RECEPTOR; TYROSINE;

ACETYLATION; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL CONTACT; CELL INVASION; CELL MIGRATION; CELL MOTILITY; COLORECTAL CANCER; CONFORMATIONAL TRANSITION; CYTOSKELETON; GLIOBLASTOMA; HUMAN; MELANOMA; NEOPLASM; NOTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION;

CELL MOVEMENT; CORTACTIN; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84863084923     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.093781     Document Type: Note

References (102)

1. Akervall, J. A., Jin, Y., Wennerberg, J. P., Zatterstrom, U. K., Kjellen, E., Mertens, F., Willen, R., Mandahl, N., Heim, S. and Mitelman, F. (1995). Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer 76, 853-859.
2. Ammer, A. G. and Weed, S. A. (2008). Cortactin branches out: roles in regulating protrusive actin dynamics. Cell Motil. Cytoskeleton 65, 687-707.
3. Artym, V. V., Zhang, Y., Seillier-Moiseiwitsch, F., Yamada, K. M. and Mueller, S. C. (2006). Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res. 66, 3034-3043.
4. Ayala, I., Baldassarre, M., Giacchetti, G., Caldieri, G., Tete, S., Luini, A. and Buccione, R. (2008). Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation. J. Cell Sci. 121, 369-378.
5. Bershteyn, M., Atwood, S. X., Woo, W. M., Li, M. and Oro, A. E. (2010). MIM and cortactin antagonism regulates ciliogenesis and hedgehog signaling. Dev. Cell 19, 270-283.
6. Bowden, E. T., Barth, M., Thomas, D., Glazer, R. I. and Mueller, S. C. (1999). An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 18, 4440-4449.
7. Boyle, S. N., Michaud, G. A., Schweitzer, B., Predki, P. F. and Koleske, A. J. (2007). A critical role for cortactin phosphorylation by Abl-family kinases in PDGFinduced dorsal-wave formation. Curr. Biol. 17, 445-451.
8. Bryce, N. S., Clark, E. S., Leysath, J. L., Currie, J. D., Webb, D. J. and Weaver, A. M. (2005). Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr. Biol. 15, 1276-1285.
9. Buday, L. and Downward, J. (2007). Roles of cortactin in tumor pathogenesis. Biochim. Biophys. Acta. 1775, 263-273.
10. Cai, J. H., Zhao, R., Zhu, J. W., Jin, X. L., Wan, F. J., Liu, K., Ji, X. P., Zhu, Y. B. and Zhu, Z. G. (2010). Expression of cortactin correlates with a poor prognosis in patients with stages II-III colorectal adenocarcinoma. J. Gastrointest. Surg. 14, 1248-1257.
11. Campbell, D. H., deFazio, A., Sutherland, R. L. and Daly, R. J. (1996). Expression and tyrosine phosphorylation of EMS1 in human breast cancer cell lines. Int. J. Cancer 68, 485-492.
12. Campbell, D. H., Sutherland, R. L. and Daly, R. J. (1999). Signaling pathways and structural domains required for phosphorylation of EMS1/cortactin. Cancer Res. 59, 5376-2385.
13. Chen, J. H., Chen, K. Y., Ma, H. I., Yu, C. P., Nieh, S., Lee, H. S. and Jin, J. S. (2010). Cortactin, fascin and survivin expression associated with clinicopathological parameters in brain gliosarcoma. Chin. J. Physiol 53, 234-244.
14. Clark, E. S., Whigham, A. S., Yarbrough, W. G. and Weaver, A. M. (2007). Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res. 67, 4227-4235.
15. Clark, E. S., Brown, B., Whigham, A. S., Kochaishvili, A., Yarbrough, W. G. and Weaver, A. M. (2009). Aggressiveness of HNSCC tumors depends on expression levels of cortactin, a gene in the 11q13 amplicon. Oncogene 28, 431-444.
16. Cowieson, N. P., King, G., Cookson, D., Ross, I., Huber, T., Hume, D. A., Kobe, B. and Martin, J. L. (2008). Cortactin adopts a globular conformation and bundles actin into sheets. J. Biol. Chem. 283, 16187-16193.
17. Crimaldi, L., Courtneidge, S. A. and Gimona, M. (2009). Tks5 recruits AFAP-110, p190RhoGAP, and cortactin for podosome formation. Exp. Cell Res. 315, 2581-2592.
18. Crostella, L., Lidder, S., Williams, R. and Skouteris, G. G. (2001). Hepatocyte Growth Factor/scatter factorinduces phosphorylation of cortactin in A431 cells in a Src kinase-independent manner. Oncogene 20, 3735-3745.
19. Croucher, D. R., Rickwood, D., Tactacan, C. M., Musgrove, E. A. and Daly, R. J. (2010). Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells. Mol. Cell Biol. 30, 5057-5070.
20. De Kimpe, L., Janssens, K., Derua, R., Armacki, M., Goicoechea, S., Otey, C., Waelkens, E., Vandoninck, S., Vandenheede, J. R., Seufferlein, T. et al. (2009). Characterization of cortactin as an in vivo protein kinase D substrate: interdependence of sites and potentiation by Src. Cell Signal 21, 253-263.
21. Desmarais, V., Yamaguchi, H., Oser, M., Soon, L., Mouneimne, G., Sarmiento, C., Eddy, R. and Condeelis, J. (2009). N-WASP and cortactin are involved in invadopodium-dependent chemotaxis to EGF in breast tumor cells. Cell Motil. Cytoskeleton 66, 303-316.
22. Du, X. L., Yang, H., Liu, S. G., Luo, M. L., Hao, J. J., Zhang, Y., Lin, D. C., Xu, X., Cai, Y., Zhan, Q. M. et al. (2009). Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma. Oncogene 28, 3714-3722.
23. Dudek, S. M., Birukov, K. G., Zhan, X. and Garcia, J. G. (2002). Novel interaction of cortactin with endothelial cell myosin light chain kinase. Biochem. Biophys. Res. Commun. 298, 511-519.
24. Egile, C., Rouiller, I., Xu, X. P., Volkmann, N., Li, R. and Hanein, D. (2005). Mechanism of filament nucleation and branch stability revealed by the structure of the Arp2/3 complex at actin branch junctions. PLoS Biol. 3, e383.
25. Eiseler, T., Hausser, A., De Kimpe, L., Van Lint, J. and Pfizenmaier, K. (2010). Protein kinase D controls actin polymerization and cell motility through phosphorylation of cortactin. J. Biol. Chem. 285, 18672-18683.
26. Fan, L., Di Ciano-Oliveira, C., Weed, S. A., Craig, A. W., Greer, P. A., Rotstein, O. D. and Kapus, A. (2004). Actin depolymerization-induced tyrosine phosphorylation of cortactin: the role of Fer kinase. Biochem. J. 380, 581-591.
27. Faoro, L., Singleton, P. A., Cervantes, G. M., Lennon, F. E., Choong, N. W., Kanteti, R., Ferguson, B. D., Husain, A. N., Tretiakova, M. S., Ramnath, N. et al. (2010). EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation. J. Biol. Chem. 285, 18575-18585.
28. Garcia-Castillo, J., Pedersen, K., Angelini, P. D., Bech-Serra, J. J., Colome, N., Cunningham, M. P., Parra-Palau, J. L., Canals, F., Baselga, J. and Arribas, J. (2009). HER2 carboxyl-terminal fragments regulate cell migration and cortactin phosphorylation. J. Biol. Chem. 284, 25302-25313.
29. Goley, E. D. and Welch, M. D. (2006). The ARP2/3 complex: an actin nucleator comes of age. Nat. Rev. Mol. Cell Biol. 7, 713-726.
30. Grassart, A., Meas-Yedid, V., Dufour, A., Olivo-Marin, J. C., Dautry-Varsat, A. and Sauvonnet, N. (2010). Pak1 phosphorylation enhances cortactin-N-WASP interaction in clathrin-caveolin-independent endocytosis. Traffic 11, 1079-1091.
31. Hashimoto, A., Hashimoto, S., Ando, R., Noda, K., Ogawa, E., Kotani, H., Hirose, M., Menju, T., Morishige, M., Manabe, T. et al. (2011). GEP100-Arf6-AMAP1-Cortactin Pathway Frequently Used in Cancer Invasion Is Activated by VEGFR2 to Promote Angiogenesis. PLoS ONE 6, e23359.
32. Hashimoto, S., Hirose, M., Hashimoto, A., Morishige, M., Yamada, A., Hosaka, H., Akagi, K., Ogawa, E., Oneyama, C., Agatsuma, T. et al. (2006). Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis. Proc. Natl. Acad. Sci. USA 103, 7036-7041.
33. Helwani, F. M., Kovacs, E. M., Paterson, A. D., Verma, S., Ali, R. G., Fanning, A. S., Weed, S. A. and Yap, A. S. (2004). Cortactin is necessary for E-cadherinmediated contact formation and actin reorganization. J. Cell Biol. 164, 899-910.
34. Higgs, H. N. and Pollard, T. D. (2001). Regulation of actin filament network formation through ARP2/3 complex: activation by a diverse array of proteins. Annu. Rev. Biochem. 70, 649-676.
35. Hill, A., McFarlane, S., Mulligan, K., Gillespie, H., Draffin, J. E., Trimble, A., Ouhtit, A., Johnston, P. G., Harkin, D. P., McCormick, D. et al. (2006). Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells. Oncogene 25, 6079-6091.
36. Hinsby, A. M., Olsen, J. V., Bennett, K. L. and Mann, M. (2003). Signaling initiated by overexpression of the fibroblast growth factor receptor-1 investigated by mass spectrometry. Mol. Cell Proteomics 2, 29-36.
37. Hirakawa, H., Shibata, K. and Nakayama, T. (2009). Localization of cortactin is associated with colorectal cancer development. Int. J. Oncol. 35, 1271-1276.
38. Hou, P., Estrada, L., Kinley, A. W., Parsons, J. T., Vojtek, A. B. and Gorski, J. L. (2003). Fgd1, the Cdc42 GEF responsible for Faciogenital Dysplasia, directly interacts with cortactin and mAbp1 to modulate cell shape. Hum. Mol. Genet. 12, 1981-1993.
39. Huang, C., Liu, J., Haudenschild, C. C. and Zhan, X. (1998). The role of tyrosine phosphorylation of cortactin in the locomotion of endothelial cells. J. Biol. Chem. 273, 25770-25776.
40. Katsube, T., Takahisa, M., Ueda, R., Hashimoto, N., Kobayashi, M. and Togashi, S. (1998). Cortactin associates with the cell-cell junction protein ZO-1 in both Drosophila and mouse. J. Biol. Chem. 273, 29672-29677.
41. Kelley, L. C., Ammer, A. G., Hayes, K. E., Martin, K. H., Machida, K., Jia, L., Mayer, B. J. and Weed, S. A. (2010a). Oncogenic Src requires a wild-type counterpart to regulate invadopodia maturation. J. Cell Sci. 123, 3923-3932.
42. Kelley, L. C., Hayes, K. E., Ammer, A. G., Martin, K. H. and Weed, S. A. (2010b). Cortactin phosphorylated by ERK1/2 localizes to sites of dynamic actin regulation and is required for carcinoma lamellipodia persistence. PLoS ONE 5, e13847.
43. Kelley, L. C., Hayes, K. E., Ammer, A. G., Martin, K. H. and Weed, S. A. (2011). Revisiting the ERK/Src cortactin switch. Commun. Integr. Biol. 4, 205-207.
44. Kim, K., Hou, P., Gorski, J. L. and Cooper, J. A. (2004). Effect of Fgd1 on cortactin in Arp2/3 complexmediated actin assembly. Biochemistry 43, 2422-2427.
45. Kinley, A. W., Weed, S. A., Weaver, A. M., Karginov, A. V., Bissonette, E., Cooper, J. A. and Parsons, J. T. (2003). Cortactin interacts with WIP in regulating Arp2/3 activation and membrane protrusion. Curr. Biol. 13, 384-393.
46. Kirkbride, K. C., Sung, B. H., Sinha, S. and Weaver, A. M. (2011). Cortactin: a multifunctional regulator of cellular invasiveness. Cell Adh. Migr. 5, 187-198.
47. Kowalski, J. R., Egile, C., Gil, S., Snapper, S. B., Li, R. and Thomas, S. M. (2005). Cortactin regulates cell migration through activation of N-WASP. J. Cell Sci. 118, 79-87.
48. Kruchten, A. E., Krueger, E. W., Wang, Y. and McNiven, M. A. (2008). Distinct phospho-forms of cortactin differentially regulate actin polymerization and focal adhesions. Am. J. Physiol. Cell Physiol. 295, C1113-C1122.
49. Lai, F. P., Szczodrak, M., Oelkers, J. M., Ladwein, M., Acconcia, F., Benesch, S., Auinger, S., Faix, J., Small, J. V., Polo, S. et al. (2009). Cortactin promotes migration and platelet-derived growth factor-induced actin reorganization by signaling to Rho-GTPases. Mol. Biol. Cell 20, 3209-3223.
50. Lapetina, S., Mader, C. C., Machida, K., Mayer, B. J. and Koleske, A. J. (2009). Arg interacts with cortactin to promote adhesion-dependent cell edge protrusion. J. Cell Biol. 185, 503-519.
51. Li, Y., Tondravi, M., Liu, J., Smith, E., Haudenschild, C. C., Kaczmarek, M. and Zhan, X. (2001). Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res. 61, 6906-6911.
52. Lin, J., Liu, J., Wang, Y., Zhu, J., Zhou, K., Smith, N. and Zhan, X. (2005). Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein. Oncogene 24, 2059-2066.
53. Luo, C., Pan, H., Mines, M., Watson, K., Zhang, J. and Fan, G. H. (2006). CXCL12 induces tyrosine phosphorylation of cortactin, which plays a role in CXC chemokine receptor 4-mediated extracellular signalregulated kinase activation and chemotaxis. J. Biol. Chem. 281, 30081-30093.
54. Lynch, D. K., Winata, S. C., Lyons, R. J., Hughes, W. E., Lehrbach, G. M., Wasinger, V., Corthals, G., Cordwell, S. and Daly, R. J. (2003). A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton. J. Biol. Chem. 278, 21805-21813.
55. Mader, C. C., Oser, M., Magalhaes, M. A., Bravo-Cordero, J. J., Condeelis, J., Koleske, A. J. and Gil-Henn, H. (2011). An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion. Cancer Res. 71, 1730-1741.
56. Martin, K. H., Jeffery, E. D., Grigera, P. R., Shabanowitz, J., Hunt, D. F. and Parsons, J. T. (2006). Cortactin phosphorylation sites mapped by mass spectrometry. J. Cell Sci. 119, 2851-2853.
57. Martinez-Quiles, N., Ho, H. Y., Kirschner, M. W., Ramesh, N. and Geha, R. S. (2004). Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate NWASP. Mol. Cell Biol. 24, 5269-5280.
58. Maruyama, S., Kurosaki, T., Sada, K., Yamanashi, Y., Yamamoto, T. and Yamamura, H. (1996). Physical and functional association of cortactin with Syk in human leukemic cell line K562. J. Biol. Chem. 271, 6631-6635.
59. Okamura, H. and Resh, M. D. (1995). p80/85 cortactin associates with the Src SH2 domain and colocalizes with v-Src in transformed cells. J. Biol. Chem. 270, 26613-26618.
60. Oser, M., Yamaguchi, H., Mader, C. C., Bravo-Cordero, J. J., Arias, M., Chen, X., Desmarais, V., van Rheenen, J., Koleske, A. J. and Condeelis, J. (2009). Cortactin regulates cofilin and N-WASp activities to control the stages of invadopodium assembly and maturation. J. Cell Biol. 186, 571-587.
61. Oser, M., Mader, C. C., Gil-Henn, H., Magalhaes, M., Bravo-Cordero, J. J., Koleske, A. J. and Condeelis, J. (2010). Specific tyrosine phosphorylation sites on cortactin regulate Nck1-dependent actin polymerization in invadopodia. J. Cell Sci. 123, 3662-3673.
62. Pant, K., Chereau, D., Hatch, V., Dominguez, R. and Lehman, W. (2006). Cortactin binding to F-actin revealed by electron microscopy and 3D reconstruction. J. Mol. Biol. 359, 840-847.
63. Patel, A. S., Schechter, G. L., Wasilenko, W. J. and Somers, K. D. (1998). Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro. Oncogene 16, 3227-3232.
64. Perrin, B. J., Amann, K. J. and Huttenlocher, A. (2006). Proteolysis of cortactin by calpain regulates membrane protrusion during cell migration. Mol. Biol. Cell 17, 239-250.
65. Ren, G., Helwani, F. M., Verma, S., McLachlan, R. W., Weed, S. A. and Yap, A. S. (2009). Cortactin is a functional target of E-cadherin-activated Src family kinases in MCF7 epithelial monolayers. J. Biol. Chem. 284, 18913-18922.
66. Rey, M., Irondelle, M., Waharte, F., Lizarraga, F. and Chavrier, P. (2011). HDAC6 is required for invadopodia activity and invasion by breast tumor cells. Eur. J. Cell Biol. 90, 128-135.
67. Rothschild, B. L., Shim, A. H., Ammer, A. G., Kelley, L. C., Irby, K. B., Head, J. A., Chen, L., Varella-Garcia, M., Sacks, P. G., Frederick, B. et al. (2006). Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. Cancer Res. 66, 8017-8025.
68. Sangrar, W., Gao, Y., Scott, M., Truesdell, P. andGreer, P. A. (2007). Fer-mediated cortactin phosphorylation is associated with efficient fibroblast migration and is dependent on reactive oxygen species generation during integrin-mediated cell adhesion. Mol. Cell Biol. 27, 6140-6152.
69. Schuuring, E., Verhoeven, E., Mooi, W. J. and Michalides, R. J. (1992). Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7, 355-361.
70. Schuuring, E., Verhoeven, E., Litvinov, S. and Michalides, R. J. (1993). The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cellsubstratum contact sites. Mol. Cell Biol. 13, 2891-2898.
71. Shvetsov, A., Berkane, E., Chereau, D., Dominguez, R. and Reisler, E. (2009). The actin-binding domain of cortactin is dynamic and unstructured and affects lateral and longitudinal contacts in F-actin. Cell Motil. Cytoskeleton 66, 90-98.
72. Smith-Pearson, P. S., Greuber, E. K., Yogalingam, G. and Pendergast, A. M. (2010). Abl kinases are required for invadopodia formation and chemokine-induced invasion. J. Biol. Chem. 285, 40201-40211.
73. Stuible, M., Dube, N. and Tremblay, M. L. (2008). PTP1B regulates cortactin tyrosine phosphorylation by targeting Tyr446. J. Biol. Chem. 283, 15740-15746.
74. Sung, B. H., Zhu, X., Kaverina, I. and Weaver, A. M. (2011). Cortactin controls cell motility and lamellipodial dynamics by regulating ECM secretion. Curr. Biol. 21, 1460-1469
75. Tanaka, S., Kunii, M., Harada, A. and Okabe, S. (2009). Generation of cortactin floxed mice and cellular analysis of motility in fibroblasts. Genesis 47, 638-646.
76. Tehrani, S., Tomasevic, N., Weed, S., Sakowicz, R. and Cooper, J. A. (2007). Src phosphorylation of cortactin enhances actin assembly. Proc. Natl. Acad. Sci. USA 104, 11933-11938.
77. Timpson, P., Lynch, D. K., Schramek, D., Walker, F. and Daly, R. J. (2005). Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor. Cancer Res. 65, 3273-3280.
78. Uruno, T., Liu, J., Zhang, P., Fan, Y., Egile, C., Li, R., Mueller, S. C. and Zhan, X. (2001). Activation of Arp2/3 complex-mediated actin polymerization by cortactin. Nat. Cell Biol. 3, 259-266.
79. Uruno, T., Liu, J., Li, Y., Smith, N. and Zhan, X. (2003). Sequential interaction of actin-related proteins 2 and 3 (Arp2/3) complex with neural Wiscott-Aldrich syndrome protein (N-WASP) and cortactin during branched actin filament network formation. J. Biol. Chem. 278, 26086-26093.
80. van Damme, H., Brok, H., Schuuring-Scholtes, E. and Schuuring, E. (1997). The redistribution of cortactin into cell-matrix contact sites in human carcinoma cells with 11q13 amplification is associated with both overexpression and post-translational modification. J. Biol. Chem. 272, 7374-7380.
81. van Rossum, A. G., de Graaf, J. H., Schuuring-Scholtes, E., Kluin, P. M., Fan, Y. X., Zhan, X., Moolenaar, W. H. and Schuuring, E. (2003). Alternative splicing of the actin binding domain of human cortactin affects cell migration. J. Biol. Chem. 278, 45672-45679.
82. van Rossum, A. G., Moolenaar, W. H. and Schuuring, E. (2006). Cortactin affects cell migration by regulating intercellular adhesion and cell spreading. Exp. Cell Res. 312, 1658-1670.
83. Vidal, C., Geny, B., Melle, J., Jandrot-Perrus, M. and Fontenay-Roupie, M. (2002). Cdc42/Rac1-dependent activation of the p21-activated kinase (PAK) regulates human platelet lamellipodia spreading: implication of the cortical-actin binding protein cortactin. Blood 100, 4462-4469.
84. Vuori, K. and Ruoslahti, E. (1995). Tyrosine phosphorylation of p130Cas and cortactin accompanies integrin-mediated cell adhesion to extracellular matrix. J. Biol. Chem. 270, 22259-22262.
85. Weaver, A. M. (2006). Invadopodia: specialized cell structures for cancer invasion. Clin. Exp. Metastasis 23, 97-105.
86. Weaver, A. M. (2008). Cortactin in tumor invasiveness. Cancer Lett. 265, 157-166.
87. Weaver, A. M., Karginov, A. V., Kinley, A. W., Weed, S. A., Li, Y., Parsons, J. T. and Cooper, J. A. (2001). Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Curr. Biol. 11, 370-374.
88. Weaver, A. M., Heuser, J. E., Karginov, A. V., Lee, W. L., Parsons, J. T. and Cooper, J. A. (2002). Interaction of cortactin and N-WASp with Arp2/3 complex. Curr. Biol. 12, 1270-1278.
89. Webb, B. A., Zhou, S., Eves, R., Shen, L., Jia, L. and Mak, A. S. (2006). Phosphorylation of cortactin by p21-activated kinase. Arch. Biochem. Biophys. 456, 183-193.
90. Webb, B. A., Jia, L., Eves, R. and Mak, A. S. (2007). Dissecting the functional domain requirements of cortactin in invadopodia formation. Eur. J. Cell Biol. 86, 189-206.
91. Weed, S. A., Du, Y. and Parsons, J. T. (1998). Translocation of cortactin to the cell periphery is mediated by the small GTPase Rac1. J. Cell Sci. 111, 2433-2443.
92. Weed, S. A., Karginov, A. V., Schafer, D. A., Weaver, A. M., Kinley, A. W., Cooper, J. A. and Parsons, J. T. (2000). Cortactin localization to sites of actin assembly in lamellipodia requires interactions with F-actin and the Arp2/3 complex. J. Cell Biol. 151, 29-40.
93. Wu, H. and Parsons, J. T. (1993). Cortactin, an 80/85-kilodalton pp60src substrate, is a filamentous actinbinding protein enriched in the cell cortex. J. Cell Biol. 120, 1417-1426.
94. Wu, H., Reynolds, A. B., Kanner, S. B., Vines, R. R. and Parsons, J. T. (1991). Identification and characterization of a novel cytoskeleton-associated pp60src substrate. Mol. Cell Biol. 11, 5113-5124.
95. Xu, X. P., Rouiller, I., Slaughter, B. D., Egile, C., Kim, E., Unruh, J. R., Fan, X., Pollard, T. D., Li, R., Hanein, D. et al. (2011). Three-dimensional reconstructions of Arp2/3 complex with bound nucleation promoting factors. EMBO J. 31, 236-247.
96. Xu, X. Z., Garcia, M. V., Li, T. Y., Khor, L. Y., Gajapathy, R. S., Spittle, C., Weed, S., Lessin, S. R. and Wu, H. (2010). Cytoskeleton alterations in melanoma: aberrant expression of cortactin, an actin-binding adapter protein, correlates with melanocytic tumor progression. Mod. Pathol. 23, 187-196.
97. Yamada, S., Yanamoto, S., Kawasaki, G., Mizuno, A. and Nemoto, T. K. (2010). Overexpression of cortactin increases invasion potential in oral squamous cell carcinoma. Pathol. Oncol. Res. 16, 523-531.
98. Yamaguchi, H. and Condeelis, J. (2007). Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim. Biophys. Acta. 1773, 642-652.
99. Zhang, X., Yuan, Z., Zhang, Y., Yong, S., Salas-Burgos, A., Koomen, J., Olashaw, N., Parsons, J. T., Yang, X. J., Dent, S. R. et al. (2007). HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol. Cell 27, 197-213.
100. Zhang, X., Shrikhande, U., Alicie, B. M., Zhou, Q. and Geahlen, R. L. (2009a). Role of the protein tyrosine kinase Syk in regulating cell-cell adhesion and motility in breast cancer cells. Mol. Cancer Res. 7, 634-644.
101. Zhang, Y., Zhang, M., Dong, H., Yong, S., Li, X., Olashaw, N., Kruk, P. A., Cheng, J. Q., Bai, W., Chen, J. et al. (2009b). Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene 28, 445-460.
102. Zhu, J., Yu, D., Zeng, X. C., Zhou, K. and Zhan, X. (2007). Receptor-mediated endocytosis involves tyrosine phosphorylation of cortactin. J. Biol. Chem. 282, 16086-16094.